Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Florida judge rules for generic, over-the-counter manufacturers of Zantac knockoffs, backing preemption claim
In dismissing claims against manufacturers of generic and over-the-counter versions of heartburn medicine Zantac, a U.
Biogen's Aduhelm probe in Congress escalates as lawmakers ask for info on FDA meetings, pricing tactics
Two high-ranking Congressional Democrats are pushing Biogen to answer for a slew of concerns over its hotly contested Alzheimer’s treatment Aduhelm, including reports of the drugmaker’s cozy relat...
Mechanical stimuli significantly influence organ growth
In addition to chemical factors, mechanical influences play an important role in the natural growth of human organs such as kidneys, lungs and mammary glands—but also in the development of tumors.
Gene therapy success offers hope for reversing rare genetic diseases
A landmark study published in the journal Nature Communications is describing the extraordinarily successful results of a Phase 1 trial testing a targeted gene therapy for children with a rare genetic...
NICE ‘no’ for Orchard Therapeutics’ gene therapy Libmeldy
The National Institute for Health and Care Excellence (NICE) has announced that it does not recommend Orchard Therapeutics’ gene therapy Libmeldy for the treatment of metachromatic leukodyst...
Stem cell therapy company Amniotics raises SEK 60 million in First North IPO to advance lead candidate PulmoStem™ into clinic
LUND, Sweden I July 12, 2021 I Amniotics AB (publ) (”Amniotics” or the “Company”), a stem cell therapy company has raised SEK60 million through its recent listing on Nasdaq Fir...
F-star Therapeutics Enters into Exclusive Licensing Agreement with AstraZeneca for Novel STING Inhibitors
CAMBRIDGE, UK and CAMBRIDGE, MA, USA I July 08, 2021 I F-star Therapeutics, Inc.
Bayer’s KERENDIA® (finerenone) Receives U.S. FDA Approval for Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes
WHIPPANY, NJ, USA I July 09, 2021 I Bayer announced today the United States (U.
Morphic Therapeutic Reports New Data from Positive Phase 1 Study of MORF-057, Oral Integrin Inhibitor Candidate for IBD
WALTHAM, MA, USA - July 09, 2021 - Morphic Therapeutic (Nasdaq.
Philip Morris strikes $1.45B deal for Vectura, sending another would-be buyer back to the drawing board
A little over a week after striking an $813 million deal for oral drug delivery company Fertin Pharma, Marlboro maker Philip Morris International is doubling down on its pharma ambitions with plans to...
With $500M in local pledges, Recipharm plans Moroccan factory to help Africa secure 'vaccine sovereignty'
With the COVID-19 pandemic flagging weaknesses in the world's pharma supply chain, contract manufacturer Recipharm is stepping up to help in Africa.
Parliament votes to expand remit of European Medicines Agency
Moves to shore up the European Medicines Agency (EMA), making it better equipped to tackle COVID-19 and future pandemics are gathering momentum, with the European Parliament today voting throu...
215
216
217
218
219
220
221
222
223
